Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-254038

Director sold 17,537 shares at an average $229.20 ($4,019,470)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Coleman Mark · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-29 Sale : show line 1 in the form 10b5-1 −6,000 $233.46 $1,400,760 41,140 D
2026-06-01 Sale : show line 2 in the form 10b5-1 −6,000 $230.30 $1,381,800 35,140 D
2026-06-02 Sale : show line 3 in the form 10b5-1 −5,537 $223.39 $1,236,910 29,603 D
Open-market sales · 17,537 sh · avg $229.20 · $4,019,470
Loading xslF345X06/ownership.xml…